Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

39.59 -6.10 (-13.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,917,858
Open 42.00
Bid (Size) 39.01 (3)
Ask (Size) 39.54 (1)
Prev. Close 45.69
Today's Range 37.12 - 42.52
52wk Range 45.37 - 103.81
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Procept (PRCT) Q2 Revenue Jumps 48%
Via The Motley Fool
Topics Artificial Intelligence
PROCEPT BioRobotics (PRCT) Earnings Transcript
Via The Motley Fool
Topics World Trade

Performance

YTD
-52.4%
-52.4%
1 Month
-30.5%
-30.5%
3 Month
-25.5%
-25.5%
6 Month
-46.4%
-46.4%
1 Year
-34.6%
-34.6%

More News

Read More
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Decline
Via Chartmill
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
From PROCEPT BioRobotics
Via GlobeNewswire
Earnings Scheduled For August 6, 2025
Via Benzinga
Where PROCEPT BioRobotics Stands With Analysts
Via Benzinga
Earnings Scheduled For April 24, 2025
Via Benzinga
4 Analysts Assess PROCEPT BioRobotics: What You Need To Know
Via Benzinga
Uncovering Potential: PROCEPT BioRobotics's Earnings Preview
Via Benzinga
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
From PROCEPT BioRobotics
Via GlobeNewswire
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
From PROCEPT BioRobotics
Via GlobeNewswire
Earnings Scheduled For February 25, 2025
Via Benzinga
How Is The Market Feeling About PROCEPT BioRobotics?
Via Benzinga
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
From PROCEPT BioRobotics
Via GlobeNewswire
WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference
From PROCEPT BioRobotics
Via GlobeNewswire
Spruce Point Sees Trouble Ahead For Procept BioRobotics
Via Benzinga
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Via Benzinga

Frequently Asked Questions

Is PROCEPT BioRobotics Corporation - Common Stock publicly traded?
Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.
What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?
PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?
The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market
What is the current price of PROCEPT BioRobotics Corporation - Common Stock?
The current price of PROCEPT BioRobotics Corporation - Common Stock is 39.59
When was PROCEPT BioRobotics Corporation - Common Stock last traded?
The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 08/07/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.